Since this week, our study continues to measure new participants. The system can now capture spiral drawings, speech and voice analyses. The update received ethical approval. We are excited to to search for new biomarkers in Parkinson’s disease and other Movement Disorders.
Since March 2020 our study is not recruiting to reduce the spread of the virus. However, our site is experiencing a significant reduction of Covid cases on intensive care units. Study reactivation is soon, we will keep you informed. We can gladly confirm that we had regular recruitment until March and provide our most current…
Read more
The ongoing Covid-19 pandemic affected all scientific conferences. Naturally, to reduce spreading of the virus, the MIE 2020 Conference was cancelled. Our planned talk on our study with interim analyses on our Machine Learning pipeline and diagnostic accuracy is still going to be published under the Conference proceedings and indexed in Pubmed. More information to…
Read more
Our study has now measured >400 participants, with 239 cases of Parkinson’s disease. 100% data completeness for each case!
Our submission entitled “The Smart Device System for Movement Disorders: Preliminary Machine Learning Results from an Observational Study” was accepted as Full Paper in the Medical Informatics Europe Conference 2020 in Geneva. The paper presents details of our Machine Learning Pipeline and promising interim results on diagnostic accuracy of our system. See you in Geneva…
Read more
Our study is half-way through and we have recruited and measured more than 300 patients. Among of them more than 200 patients with Parkinson’s disease. Our system runs stable and our interim recruitment goal of acquiring > 250 participants with 100% data completeness has been achieved. Cheers! The advanced data analytics pipeline is continuously improving…
Read more
Tweet from Hannes Ametsreiter (CEO of Vodafone Germany)
We have recruited and measured 200 participants. Among of them, 101 patients with Parkinson’s disease, 38 with other movement disorders and 41 healthy subjects. Happy to know that recruitment remains stable!!
A new collaboration has started with the Institut of Geophysics (headed by Prof. Christine Thomas). We are designing a study to systematically assess measurement accuracy of our system by comparing to one of most precise Goldstandards: Seismometers! Christine Thomas, Angelo Pisconti and Rafael Abreu.
We have successfully recruited and measured 100 participants. Among of them, 52 patients with Parkinson’s disease, 14 with other Movement disorders and 34 healthy one. Hope to keep this great start.